SlateStone Wealth’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.04M | Buy |
7,505
+484
| +7% | +$196K | 0.28% | 84 |
|
|
2025
Q1 | $3.49M | Buy |
7,021
+349
| +5% | +$174K | 0.35% | 75 |
|
|
2024
Q4 | $3.47M | Buy |
6,672
+524
| +9% | +$273K | 0.34% | 79 |
|
|
2024
Q3 | $3.8M | Buy |
6,148
+279
| +5% | +$173K | 0.34% | 75 |
|
|
2024
Q2 | $3.25M | Buy |
5,869
+767
| +15% | +$424K | 0.35% | 70 |
|
|
2024
Q1 | $2.97M | Buy |
5,102
+277
| +6% | +$161K | 0.3% | 78 |
|
|
2023
Q4 | $2.56M | Sell |
4,825
-1,626
| -25% | -$863K | 0.33% | 75 |
|
|
2023
Q3 | $3.27M | Buy |
6,451
+768
| +14% | +$389K | 0.47% | 58 |
|
|
2023
Q2 | $2.97M | Sell |
5,683
-142
| -2% | -$74.1K | 0.56% | 38 |
|
|
2023
Q1 | $3.36M | Buy |
5,825
+1,948
| +50% | +$1.12M | 0.7% | 34 |
|
|
2022
Q4 | $2.14M | Buy |
3,877
+1,209
| +45% | +$666K | 0.52% | 39 |
|
|
2022
Q3 | $1.35M | Buy |
2,668
+282
| +12% | +$143K | 0.36% | 58 |
|
|
2022
Q2 | $1.3M | Buy |
2,386
+792
| +50% | +$430K | 0.33% | 61 |
|
|
2022
Q1 | $941K | Buy |
+1,594
| New | +$941K | 0.21% | 80 |
|
|
2019
Q4 | – | Sell |
-842
| Closed | -$245K | – | 224 |
|
|
2019
Q3 | $245K | Sell |
842
-90
| -10% | -$26.2K | 0.07% | 148 |
|
|
2019
Q2 | $274K | Sell |
932
-50
| -5% | -$14.7K | 0.08% | 148 |
|
|
2019
Q1 | $269K | Buy |
+982
| New | +$269K | 0.08% | 141 |
|